Trial Profile
Phase II Trial of Docetaxel in Patients With Metastatic or Inoperable Medullary Thyroid Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2016
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- Acronyms Docetaxel-MTC
- 25 Sep 2016 Status changed from recruiting to completed.
- 14 Jun 2011 New trial record